Dr. Zhiyu Chen 陈治宇
Chief Physician
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical treatment of digestive tract tumors, including malignant gastrointestinal stromal tumors. Focuses on rare digestive tumors such as neuroendocrine tumors.
Dr. Chen holds a doctorate in oncology and serves as Chief Physician at Fudan University Shanghai Cancer Center. Research focuses on medical treatment of digestive malignancies, including metastatic colorectal cancer conversion therapy, targeted therapy, and drug resistance mechanisms. Dr. Chen has published over 20 papers and leads three provincial-level research projects.
Professional roles
- Member, CSCO Neuroendocrine Tumor Committee
- Member, CSCO Gastrointestinal Stromal Tumor Committee
- Vice Chair, Shanghai Anti-Cancer Association Neuroendocrine Tumor Committee
- Standing Committee Member, Chinese Research Hospital Association Precision Medicine and Oncology MDT Professional Committee
Name order: in Chinese the family name comes first (Chen Zhiyu). Papers usually list the name as Zhiyu Chen or Chen Z.
Selected publications
51 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Med, 2025 (senior author): Combination of LowDose Epigenetic Modifiers and TIC10 for the Activation of Antitumor Immunity and Inhibition of Tumor Growth in Gastrointestinal Cancer. PubMed 40673385
- Front Oncol, 2022 (senior author): Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy. PubMed 35646700
- Front Oncol, 2022 (senior author): Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy. PubMed 35280779
- Eur J Surg Oncol, 2019 (senior author): UQCRC1 downregulation is correlated with lymph node metastasis and poor prognosis in CRC. PubMed 30842031
- Transl Oncol, 2019 (senior author): Advantage of Next-Generation Sequencing in Dynamic Monitoring of Circulating Tumor DNA over Droplet Digital PCR in Cetuximab Treated Colorectal Cancer Patients. PubMed 30562681
- Oncol Lett, 2018 (senior author): Influence of hypoxia-related genetic polymorphisms on the prognosis of patients with metastatic gastric cancer treated with EOF. PubMed 29399184
- Cancer Chemother Pharmacol, 2015 (first author): Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial. PubMed 25572362
- Tumour Biol, 2014 (senior author): Overexpression of miR-145 increases the sensitivity of vemurafenib in drug-resistant colo205 cell line. PubMed 24248543
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion